Drug Profile
Tc 99m fanolesomab
Alternative Names: Anti-CD15 IgM monoclonal antobody Tc 99m; Fanolesomab-Tc 99m; LeuTech; NeutroSpec; Tc 99m-anti-SSEA-1; Tc 99m-RB5 IgM; Technetium 99m-labeled mouse anti-CD-15 IgM monoclonal antibodyLatest Information Update: 21 Dec 2005
Price :
$50
*
At a glance
- Originator Palatin Technologies; Wistar Institute
- Class Heavy metals; Monoclonal antibodies; Monoclonal antibody diagnostics; Radiopharmaceutical diagnostics
- Mechanism of Action Radionuclide imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Market Withdrawal Infections
Most Recent Events
- 19 Dec 2005 Withdrawn for Infection diagnosis in USA (IV)
- 05 Dec 2005 Palatin and Tyco Healthcare communicated to healthcare providers several reports in patients with severe cardiopulmonary co-morbidities who experienced life-threatening or fatal reactions after administration of Tc 99m fanolesomab
- 31 Aug 2004 Launched for Infection diagnosis in USA (IV)